BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25432943)

  • 1. TB vaccine development: where are we and why is it so difficult?
    Wilkie ME; McShane H
    Thorax; 2015 Mar; 70(3):299-301. PubMed ID: 25432943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates.
    Jeyanathan M; Shao Z; Yu X; Harkness R; Jiang R; Li J; Xing Z; Zhu T
    PLoS One; 2015; 10(8):e0135009. PubMed ID: 26252520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of new tuberculosis vaccine in children.
    Pang Y; Zhao A; Cohen C; Kang W; Lu J; Wang G; Zhao Y; Zheng S
    Hum Vaccin Immunother; 2016 Apr; 12(4):960-70. PubMed ID: 27002369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.
    Horvath CN; Xing Z
    Adv Exp Med Biol; 2013; 783():267-78. PubMed ID: 23468114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the development of TB Vaccines.
    Zenteno-Cuevas R
    Curr Pharm Biotechnol; 2013; 14(11):940-6. PubMed ID: 24372249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel vaccination strategies and approaches against human tuberculosis.
    Méndez-Samperio P
    Scand J Immunol; 2019 Aug; 90(2):e12774. PubMed ID: 31054193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating knowledge of Mycobacterium tuberculosis pathogenesis for the design of better vaccines.
    Mascart F; Locht C
    Expert Rev Vaccines; 2015; 14(12):1573-85. PubMed ID: 26517361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and solutions for a rational vaccine design for TB-endemic regions.
    Gowthaman U; Mushtaq K; Tan AC; Rai PK; Jackson DC; Agrewala JN
    Crit Rev Microbiol; 2015; 41(3):389-98. PubMed ID: 24495096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuberculosis vaccine development at a divide.
    Kaufmann SH
    Curr Opin Pulm Med; 2014 May; 20(3):294-300. PubMed ID: 24626237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SATVI - after 10 years closing in on a new and better vaccine to prevent tuberculosis.
    Hanekom WA; Hawkridge A; Mahomed H; Scriba TJ; Tameris M; Hughes J; Hatherill M; Day CL; Hussey GD
    S Afr Med J; 2012 Mar; 102(6):438-41. PubMed ID: 22668930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tuberculosis vaccine challenge.
    Brennan MJ
    Tuberculosis (Edinb); 2005; 85(1-2):7-12. PubMed ID: 15687021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human biomarkers: can they help us to develop a new tuberculosis vaccine?
    Fletcher HA; Dockrell HM
    Future Microbiol; 2016 Jun; 11():781-7. PubMed ID: 27203133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis vaccine development: from classic to clinical candidates.
    Li J; Zhao A; Tang J; Wang G; Shi Y; Zhan L; Qin C
    Eur J Clin Microbiol Infect Dis; 2020 Aug; 39(8):1405-1425. PubMed ID: 32060754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New tuberculosis vaccines.
    Martín Montañés C; Gicquel B
    Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():57-62. PubMed ID: 21420568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization.
    Xing Z; Lichty BD
    Tuberculosis (Edinb); 2006; 86(3-4):211-7. PubMed ID: 16504584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mycobacterium tuberculosis virulence: insights and impact on vaccine development.
    Delogu G; Provvedi R; Sali M; Manganelli R
    Future Microbiol; 2015; 10(7):1177-94. PubMed ID: 26119086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a new tuberculosis vaccine: is there value in the mucosal approach?
    Diogo GR; Reljic R
    Immunotherapy; 2014; 6(9):1001-13. PubMed ID: 25341121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuberculosis vaccines: time to think about the next generation.
    Kaufmann SH
    Semin Immunol; 2013 Apr; 25(2):172-81. PubMed ID: 23706597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis.
    Williams A; Hatch GJ; Clark SO; Gooch KE; Hatch KA; Hall GA; Huygen K; Ottenhoff TH; Franken KL; Andersen P; Doherty TM; Kaufmann SH; Grode L; Seiler P; Martin C; Gicquel B; Cole ST; Brodin P; Pym AS; Dalemans W; Cohen J; Lobet Y; Goonetilleke N; McShane H; Hill A; Parish T; Smith D; Stoker NG; Lowrie DB; Källenius G; Svenson S; Pawlowski A; Blake K; Marsh PD
    Tuberculosis (Edinb); 2005; 85(1-2):29-38. PubMed ID: 15687025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The dream of a vaccine against tuberculosis; new vaccines improving or replacing BCG?
    Martín C
    Eur Respir J; 2005 Jul; 26(1):162-7. PubMed ID: 15994403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.